Research Identifies Mechanism Responsible for Eye Disorder - Duane Syndrome
The findings could provide the key to reversing the condition and unlocking the causes of movement disorders in other parts of the body
A research team from King's College London and the University of Exeter Medical School has identified how a genetic mutation acts during the development of nerves responsible for controlling eye muscles, resulting in movement disorders such as Duane Syndrome, a form of squint.
Duane Syndrome usually causes vision problems, but can be accompanied by malformations of the skeleton, eyes, ears, kidneys and nervous system - but more commonly occurs in isolation.
Most sufferers of the condition are diagnosed by the age of 10; it is more prevalent in women, and in the left eye. It is believed to affect around half a million people worldwide.
In Duane Syndrome, eye muscles contract and relax when they should not. It develops in the womb where it affects nerve growth to the eye. Sufferers of the syndrome have limited eye movement sideways towards the ear or nose. When the eye moves towards the nose the eyeball pulls into the socket, closing the eyelids and sometimes forcing the eye movement up or down.
The discovery could lead to therapies and a better understanding of how genetic mutations of the nervous system cause movement disorders in other parts of the body - with a long term view to encouraging the re-growth of damaged cells.
The research is published in Proceedings of the National Academy of Sciences.
As nerves develop in the womb
they respond to signals that tell them
in which direction to grow.
Some signals encourage them
to grow to a particular part of the body,
while other signals tell them to avoid certain areas.
When the system works as it should,
the right type of nerve grows to
the appropriate part of the body.
The surface of growing nerves includes identification receptors that respond to signals from secreted proteins. The protein mutated in Duane Syndrome acts as a switch that weighs up incoming signals from the receptors in this way the nerve knows whether it must grow towards a part of the body or be repulsed away.
In conditions such as Duane Syndrome,
the signalling breaks down and the nerve
cells are unable to distinguish between
a signal of attraction or repulsion.
As a result, the nerves that control eye movements
grow to the wrong muscles causing limited
or complete loss of eye movement.
If not corrected surgically,
this can lead to partial blindness in later life.
This recent research has provided new insights into how this 'switch signal' system works and how it has failed in cases of Duane Syndrome, causing the 'wiring up' of the wrong muscle or 'overshooting' of nerve development past the correct muscle.
The findings are likely to lead to further study which will identify how the 'switch signal' mechanism could be harnessed to selectively change nerve cell development behaviour, how the protein could be targeted to encourage damaged cells to re-grow, and how the 'switch' could be manipulated to reverse damage.
Dr. John Chilton, senior lecturer at the University of Exeter Medical School, commented: "We have focused our research on eye movements and conditions such as Duane Syndrome because it is a relatively simple anatomical system six muscles controlled by three nerves - and there is not much cross over with other nerves in the developing head. Our findings are exciting for two reasons: the first is that they provide real hope for the development of therapies that could reverse eye movement disorders; the second is that, with additional research, they could be applied to other, more complex nerve and muscle groups that control, say, legs or arms. The scope could be phenomenal."
Sarah Guthrie, Professor of Developmental Neurobiology at King's College London said: "Investigating the signalling pathways that regulate alpha2-chimaerin helps us to understand defects in the cranial nerves which lead to eye movement disorders and visual problems. The results of this early study are very exciting, and could have an impact on the approach to treating eye movement disorders and other nerve wiring defects in the future."
Original article: http://www.eurekalert.org/pub_releases/2012-08/tpco-rim082112.php